AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci179572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Manuel A Torres Acosta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, AMP-Activated Protein Kinases, Tumor Microenvironment, Melanoma, Experimental. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
CD4 + FOXP3 + Treg cells maintain self tolerance, suppress the immune response to cancer, and protect against tissue injury during acute inflammation. Treg cells require mitochondrial metabolism to function, but how Treg cells adapt their metabolic programs to optimize their function during an immune response occurring in a metabolically stressed microenvironment remains unclear. Here, we tested whether Treg cells require the energy homeostasis–maintaining enzyme AMPK to adapt to metabolically aberrant microenvironments caused by malignancy or lung injury, finding that AMPK is dispensable for Treg cell immune-homeostatic function but is necessary for full Treg cell function in B16 melanoma tumors and during influenza virus pneumonia. AMPK-deficient Treg cells had lower mitochondrial mass and exhibited an impaired ability to maximize aerobic respiration. Mechanistically, we found that AMPK regulates DNA methyltransferase 1 to promote transcriptional programs associated with mitochondrial function in the tumor microenvironment. During viral pneumonia, we found that AMPK sustains metabolic homeostasis and mitochondrial activity. Induction of DNA hypomethylation was sufficient to rescue mitochondrial mass in AMPK-deficient Treg cells, linking AMPK function to mitochondrial metabolism via DNA methylation. These results define AMPK as a determinant of Treg cell adaptation to metabolic stress and offer potential therapeutic targets in cancer and tissue injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine.
- Medical Scientist Training Program.
- Driskill Graduate Program.
- Division of Allergy and Immunology.
- Department of Dermatology.
- Department of Pathology.
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NIH HHS
- NIA NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Torres Acosta, M. A., Gurkan, J. K., Liu, Q., Mambetsariev, N., Reyes Flores, C., Helmin, K. A., Joudi, A. M., Morales-Nebreda, L., Cheng, K., Abdala-Valencia, H., Weinberg, S. E., & Singer, B. D. (2025). AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia. Journal of Clinical Investigation. https://doi.org/10.1172/jci179572
Vancouver
Torres Acosta MA, Gurkan JK, Liu Q, Mambetsariev N, Reyes Flores C, Helmin KA, et al. AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia. Journal of Clinical Investigation. 2025. doi:10.1172/jci179572
BibTeX
@article{TorresAcosta2025,
author = {Torres Acosta, Manuel A and Gurkan, Jonathan K and Liu, Qianli and Mambetsariev, Nurbek and Reyes Flores, Carla and Helmin, Kathryn A and Joudi, Anthony M and Morales-Nebreda, Luisa and Cheng, Kathleen and Abdala-Valencia, Hiam and Weinberg, Samuel E and Singer, Benjamin D},
title = {AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci179572}
}
EUVIMED